NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

They did not and this has been conclusively shown by me time and time again. You all go away when I do it. And then come back months later with the same argument.

I do not "go away" on this debate topic. Perhaps because I get only one post per day (thanks to you) you think that is the case. However, I will continue to contend that the lawsuit ruling you reference does not decide the issue of whether they conducted an efficacy IA in 2015. There are a lot of reasons why the court would not have known if an efficacy IA was done, the most obvious being that it was conducted in 2015 after the lawsuit discovery time frame. There are also some who contend they started an efficacy IA but never "finished" it. There was no report because the data was obviously so bad that they they kiboshed the whole thing and pretended it never happened. I don't know if I believe that, but it wouldn't surprise me in the least. In any event, they told us they were going to do an efficacy IA and it was part of the trial protocol, so I have no reason to think they did not even though they chose to suppress the results. It certainly explains what happened in that time frame. Otherwise, why would they have chosen to the change the course of the trial away from PFS? What basis would they have had for doing that?